Provided by Tiger Fintech (Singapore) Pte. Ltd.

TransCode Therapeutics Inc.

0.3070
+0.00702.33%
Volume:2.09M
Turnover:634.61K
Market Cap:7.17M
PE:0.00
High:0.3254
Open:0.3178
Low:0.2850
Close:0.3000
Loading ...
May 10, 2023

Major Issues Report

8-K - Current report
Apr 14, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2023

Major Issues Report

8-K - Current report
Feb 17, 2023

Major Issues Report

8-K - Current report
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2023

Major Issues Report

8-K - Current report
Feb 01, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 20, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Dec 14, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 09, 2022

Major Issues Report

8-K - Current report
Nov 30, 2022

Major Issues Report

8-K - Current report
Nov 30, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 28, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals